FDA grants orphan status to two Lux products

The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.

Related Content:

ArticlesInflammation & Infection

A melting pot of curious minds congregate in-person and virtually at this year’s ESCRS

World Sight Day 2021: How the eye care industry is celebrating #LoveYourEyes

ASRS 39th Annual Scientific Meeting: A review of findings reported